A new study shows that cigarette smoke can speed aging in the eye and may lead to age-related macular degeneration (AMD). AMD is the main cause of vision loss in people aged 50 and older. People who smoke are four times more likely to develop AMD than non-smokers.
Researchers used experiments in mice and tests of donated human retinal pigmented epithelial cells (RPE cells). They compared young and older mice after short and long smoke exposure. Smoking caused changes in gene activity and in chromatin, the DNA structure that helps control genes. Similar changes appeared in human cells. Scientists now want to find which changes are temporary and which are permanent.
Difficult words
- degeneration — process where body tissue becomes worse over time
- retinal — related to the retina at the back of eye
- chromatin — material in cells that contains and organizes DNA
- donate — give something for use without paymentdonated
- exposure — the state of being put near something harmful
- vision loss — partial or complete loss of sight
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why do scientists want to know which changes are temporary and which are permanent?
- What can people do to protect their eyes from cigarette smoke?
Related articles
Drug‑resistant Salmonella in children’s food and water in Karamoja
A peer‑reviewed study found drug‑resistant Salmonella in nearly half of food and water consumed by under‑fives in Karamoja. High resistance to azithromycin and other drugs raises health, economic and development concerns.
Western Pacific priorities as WHO adapts after US withdrawal
WHO regional director Saia Maʻu Piukala outlines challenges and priorities for the Western Pacific as the organisation adapts after the US withdrawal. Key events include the World Health Summit in Berlin (12–14 October) and the Fiji Regional Committee (20–24 October 2025).
New inflammatory pathway may explain some rheumatoid arthritis treatment failures
A Washington State University study found that a lesser-known TWEAK–Fn14 pathway can join with TNF to increase inflammation. Blocking Fn14 reduced this surge and may explain why some patients do not respond to TNF inhibitors.